The compliance risk most natural medicine practitioners don't see coming: TGA advertising obligations for health professionals (2026)

During seven years working inside a TGA-regulated health marketing operation, the same situation played out more times than I could count. A practitioner — a naturopath, a nutritionist, a herbalist — would share a post about a listed medicine they genuinely believed in. An unboxing of their favourite products from one of their distributors. A video talking about their own experience using a product as part of their daily routine. Always well-intentioned. Often generous.

And then our marketing team would have to reach out and ask them to change or remove it. Not because we did not value the endorsement — we did. But because under the Therapeutic Goods Advertising Code, the moment a practitioner shares content that promotes a therapeutic good to a general audience, they become an advertiser of that product, regardless of whether they make it, sell it, or have any commercial arrangement with the brand at all.

Most natural medicine practitioners have a working understanding of their advertising obligations. The challenge is that the regulatory detail changes often, and what was common practice two years ago may sit differently under current guidance. The line between sharing clinical knowledge and publishing a therapeutic claim can shift depending on how content is framed, what platform it appears on, and what product it references.

The Therapeutic Goods Advertising Code 2021 defines an advertiser as anyone who causes an advertisement to be published — a definition broader than most expect.

It does not require a commercial relationship with the product or that you be a sponsor or distributor. Under s.3 of the Code, if you share content on a public platform that promotes a listed medicine — recommending it, describing its therapeutic benefits, linking it to a health outcome — you are acting as an advertiser of that product.

In practice, this means the same rules that apply to the supplement brand apply to you. Claims must be consistent with the product's registered indications under the TGA's Permitted Indications framework. Certain representations are prohibited under s.22 and Schedule 3 of the Code. Content must not encourage inappropriate self-diagnosis or self-medication. Mandatory statements — the AUST number, sponsor name, and 'always read the label and follow the directions for use' — are required in advertising regardless of who publishes it.

None of that changes because the content came from a clinician rather than a marketing department.

A practical example: a naturopath publishes an Instagram Reel discussing the immune-supporting benefits of a specific magnesium supplement they recommend to clients. The post names the product, describes its benefits in clinical terms, and links to the brand's website. Under the Code's definition, this is an advertisement for a therapeutic good — and the naturopath is the advertiser for the purposes of that content. The same compliance obligations that govern the brand's own advertising apply.

When a practitioner shares non-compliant content about a listed medicine, the regulatory exposure does not land entirely on the practitioner. The product's sponsor — the brand — carries an obligation under the Code to monitor content on platforms they control and to take reasonable steps to address non-compliant third-party content associated with their advertising.

A well-intentioned post about a product you recommend can therefore trigger a compliance response from the brand itself — not because the brand does not appreciate the support, but because they may need to act to manage their own compliance exposure.

This dynamic can be unexpected for practitioners used to brand relationships built primarily on trust and goodwill. A brand that reaches out to request amendment or removal of a practitioner's post is not being adversarial — they are managing a compliance obligation that flows from the same Code that applies to the practitioner. Understanding this shared compliance landscape changes how both parties approach the relationship.

For brands: the practical implication is that a practitioner advocacy or ambassador programme requires the same compliance infrastructure as direct brand advertising. Briefing practitioners on permitted claim language — providing them with a list of approved indications, flagging what they cannot say — is not optional. It is the brand's most effective tool for managing the compliance risk that practitioner content creates.

Naturopaths, herbalists, and nutritionists are not currently AHPRA-registered professions, so the AHPRA Guidelines for Advertising a Regulated Health Service do not apply directly to most practitioners in this community.

However, practitioners in multi-modality clinics that include AHPRA-registered practitioners — or whose promotional material references such services — may find their content touches the AHPRA framework regardless of their own registration status. The testimonial restrictions under s.133(1)(c) of the Health Practitioner Regulation National Law and the before-and-after prohibitions under s.133(1)(c) are particularly easy to encounter without realising it — especially in clinic social media accounts that promote both registered and unregistered services on the same platform.

Additionally, practitioners who are already familiar with the AHPRA advertising framework will be better placed should any registration change arrive in future. The natural therapy registration debate in Australia is ongoing. Practitioners who have built compliant advertising habits are structurally advantaged regardless of where that debate lands.

For practitioners in states and territories that have adopted a Code of Conduct for unregistered health practitioners, an additional conduct layer applies independently of both AHPRA registration and professional association membership. The terminology and administering body differ by jurisdiction: NSW uses the Schedule 3 Code of Conduct (Public Health Regulation 2022); QLD, TAS and SA operate under the National Code of Conduct for Health Care Workers framework; and VIC applies the General Health Service Providers Code of Conduct under the Health Complaints Act 2016. WA does not currently have an equivalent harmonised code — in WA, Australian Consumer Law is the primary baseline obligation for unregistered practitioners.

The compliance gap is not a motivation problem — practitioners are not indifferent to their obligations. The gap is one of access and pace.

The Therapeutic Goods Advertising Code is a technical document drafted for regulatory and industry audiences. It runs to a schedule of technical provisions, cross-references to the Therapeutic Goods Act 1989, and is supplemented by TGA guidance notes on specific advertising matters — including social media content, endorsements, and digital formats — that sit alongside the Code and are updated independently of it.

For a practitioner managing a clinical caseload, staying current with TGA advertising guidance while also monitoring changes to FSANZ food standards and any relevant association conduct requirements is a significant ongoing task. The TGA itself acknowledges this challenge in its compliance education materials, noting that the advertising rules are complex and that practitioner education is a priority area.

The registration debate in the natural medicine community involves genuine professional stakes. But the advertising obligations exist now, independently of where that debate lands. A practitioner who publishes non-compliant content today carries regulatory risk today — regardless of what the regulatory framework looks like in three years.

1. Know your content category. Content about your services sits in a different regulatory space to content about specific therapeutic products. A post discussing your naturopathic consultation approach is service advertising. A post describing the benefits of a specific listed medicine is product advertising. That distinction changes how you approach your marketing and what rules apply.

2. Check claims before you post. Look up the product on the TGA's public ARTG search tool to see exactly what it is registered to claim — before your content goes live. The permitted indications for listed ingredients are publicly available. If your planned claim is not within those indications, do not publish it.

3. Stay current with TGA guidance. The TGA publishes advertising guidance notes and compliance updates regularly. Subscribe to TGA advertising email updates to receive these directly. TGA guidance supplements the Code and is updated more frequently — staying current with guidance is as important as knowing the Code itself.

4. Document that you checked. Regulators ask: what steps did you take before publishing? A record showing you assessed your content against the relevant framework — the specific product's ARTG listing, the applicable Code provisions — is your primary protection if a compliance question arises. The absence of that record is consistently cited as an aggravating factor in TGA enforcement responses.

5. When in doubt, ask the brand. The brand's marketing or regulatory team will have permitted indications to hand and will appreciate the question more than the alternative. A practitioner who asks before posting is managing the brand's compliance risk as well as their own — most brands will respond to that request promptly and helpfully.

The Therapeutic Goods Advertising Code is currently under formal review by the TGA (2025–26). This guide reflects the current Code. Guidance may be subject to change. This content does not constitute legal advice. For binding interpretations, consult a qualified regulatory professional.

• Publishing without checking the complete advertisement’s overall impression.
• Treating one regulator’s checklist as coverage for every applicable framework.
• Failing to retain evidence showing what was reviewed and approved before publication.

CompliGUARD reviews the complete advertisement against TGA · AHPRA · FSANZ · ACCC requirements, identifies clause-level risks, proposes compliant wording, and retains the result in an audit trail before publication.